Ocular Therapeutix™ Appoints Steve Meyers to Chief Commercial Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Ocular Therapeutix (OCUL) Appoints Steve Meyers as Chief Commercial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BEDFORD, Mass., Feb. 13, 2024 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and.
Certain Common stock of Ocular Therapeutix, Inc. are subject to a Lock-Up Agreement Ending on 11-FEB-2024. These Common stock will be under lockup for 60 days starting from 13-DEC-2023 to.